Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Tharimmune (THAR)
NASDAQ:THAR
Holding THAR?
Track your performance easily
THAR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.54 - $142.50
Previous Close$2.84
Volume32.39K
Average Volume (3M)38.21K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)$7.90M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.27
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-47.92
Shares Outstanding1,148,760
10 Day Avg. Volume68,993
30 Day Avg. Volume38,207
Standard Deviation0.46
R-Squared0.03
Alpha-0.13
Financial Highlights & Ratios
Price to Book (P/B)0.49
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Tharimmune News
PremiumCompany Announcements
Tharimmune Announces Intent to Acquire Intract Pharma
PremiumCompany Announcements
Tharimmune Expands Immunology Pipeline with Intract License
Ownership Overview
25.06% Insiders
0.01% Mutual Funds
<0.01% Other Institutional Investors
74.93% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
THAR FAQ
What was Tharimmune’s price range in the past 12 months?
Tharimmune lowest stock price was $2.54 and its highest was $142.50 in the past 12 months.
What is Tharimmune’s market cap?
Currently, no data Available
When is Tharimmune’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Tharimmune’s earnings last quarter?
Currently, no data Available
Is Tharimmune overvalued?
According to Wall Street analysts Tharimmune’s price is currently Overvalued.
Does Tharimmune pay dividends?
Tharimmune does not currently pay dividends.
What is Tharimmune’s EPS estimate?
Tharimmune’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Tharimmune have?
Tharimmune has 1,148,760 shares outstanding.
What happened to Tharimmune’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Tharimmune?
Currently, no hedge funds are holding shares in THAR
---
Tharimmune Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-96.81%
12-Months-Change
Fundamentals
Return on Equity
-181.81%
Trailing 12-Months
Asset Growth
79.53%
Trailing 12-Months
Company Description
Tharimmune
Hillstream BioPharma Inc is a biotechnology company developing novel therapeutic candidates targeting ferroptosis, an emerging new anti-cancer mechanism resulting in iron mediated cell death for drug resistant and devastating cancers.
---
THAR Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Axsome Therapeutics
―
Clearside Biomedical
―
Fennec Pharmaceuticals
―
Galera Therapeutics
―
Best Analysts Covering THAR
1 Year
1 Year Success Rate
0/1 ratings generated profit
1 Year Average Return
-59.20%
initiated a buy rating 7 months ago
Copying Ashok Kumar's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -59.20% per trade.
---